Christian Weyer, SVP, Research & Development at AMYLIN PHARMACEUTICALS INC (AMLN), sold 1,231 shares at $17.11 ($21K) on 2012-03-01, disclosed to the SEC on 2012-03-02.
Open-market sale of $21k AMLN by SVP, Research & Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ICPT | SELL | 2020-01-27 | $136K | — | Filing → |
| ICPT | SELL | 2019-12-30 | $390K | — | Filing → |
| ICPT | SELL | 2019-12-02 | $106K | — | Filing → |